Skip to content

BioLife Solutions BLFS Allowance for doubtful accounts

Allowance for doubtful accounts at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
Danaher logo
DanaherDHR
Azenta logo
AzentaAZTA
Baxter International logo
Baxter InternationalBAX
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
Charles River Laboratories logo
Charles River LaboratoriesCRL

Other financials

Income statement

See full
Revenue$27.5M+24.7%
Gross profit$17.5M+18.2%
Operating income$27.0K+105%
Net income$1.2M+365%
EPS (diluted)$0.02

Balance sheet

See full
Cash & equivalents$22.8M-65.9%
Total debt$17.4M-35.6%
Total equity$372.2M+5.6%
Total assets$400.9M+1.5%

Cash flow

See full
Operating cash flow-$491.0K-128%
CapEx$167.0K-4.6%
Free cash flow-$658.0K-142%

Valuation

See full
Market cap$1.34B+33.1%
Enterprise value$1.34B+38.1%
P/S13.5×+0.6×

Profitability

See full
Gross margin66.9%
Operating margin-16.7%
Net margin-68.7%
FCF margin-15.9%+18.7pp

Returns & leverage

See full
Return on equity-14.5%-4.7pp
Debt / equity0.0×
Current ratio7.3×+2.6×

Where this comes from

Reported directly by BioLife Solutions in its filing.

Tagged under the XBRL concept us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent.

The official record: BioLife Solutions’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about BioLife Solutions's allowance for doubtful accounts.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is BioLife Solutions's allowance for doubtful accounts?
BioLife Solutions (BLFS) reported allowance for doubtful accounts of $27K in Q1 2026.
How has BioLife Solutions's allowance for doubtful accounts changed year-over-year?
BioLife Solutions's allowance for doubtful accounts decreased by 76.9% year-over-year, from $117K to $27K.
What is the long-term trend for BioLife Solutions's allowance for doubtful accounts?
Over 3 years (2022 to 2025), BioLife Solutions's allowance for doubtful accounts has grown at a -69.0% compound annual growth rate (CAGR), from $739K to $22K.